Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Augmentation of pulmonary host defense against Pseudomonas by FcγRIIA cDNA transfer to the respiratory epithelium
Stefan Worgall, … , Alan D. Schreiber, Ronald G. Crystal
Stefan Worgall, … , Alan D. Schreiber, Ronald G. Crystal
Published August 15, 1999
Citation Information: J Clin Invest. 1999;104(4):409-418. https://doi.org/10.1172/JCI5432.
View: Text | PDF
Article

Augmentation of pulmonary host defense against Pseudomonas by FcγRIIA cDNA transfer to the respiratory epithelium

  • Text
  • PDF
Abstract

Fcγ receptors on the surface of phagocytic cells bind the Fc region of IgG and mediate binding, phagocytosis, and destruction of particulate antigens opsonized by the antigen-specific IgG molecule. The present study evaluates the feasibility of converting lung epithelial cells into phagocytic cells using adenovirus (Ad) vector–mediated gene transfer of FcγRIIA cDNA to induce expression of the human FcγRIIA receptor. Binding and phagocytosis of opsonized sheep red blood cells (SRBCs) by the A549 human lung epithelial cell line after Ad-mediated FcγRIIA gene transfer was demonstrated using light and fluorescence microscopy and phagocytic assays with 51Cr-labeled SRBCs. When A549 cells were infected with an Ad vector expressing a FcγRIIA mutant in which 2 of 3 cytoplasmic tyrosines have been replaced with phenylalanine, only binding, but not phagocytosis, of opsonized SRBCs was observed. In vivo expression of FcγRIIA in the lung after intratracheal administration of the AdFcγRIIA enhanced clearance of opsonized Pseudomonas aeruginosa from the lung in normal rats and in mice deficient in Fcγ receptor expression. Similar results were observed with a chimeric FcγRIIA construct containing the extracellular domain of FcγRIIIA. Together, these data demonstrate that Ad-mediated FcγRIIA receptor cDNA expression can mediate the binding and phagocytosis of opsonized particulate antigens by normally nonphagocytic cells, suggesting that gene-transfer strategies might be used to utilize nonphagocytic cells to clear bacteria or other opsonized particulate antigens from the respiratory tract.

Authors

Stefan Worgall, Petr Bezdicek, Moo-Kyung Kim, Jong-Gu Park, Ravi Singh, Melpo Christofidou-Solomidou, Alice Prince, Imre Kovesdi, Alan D. Schreiber, Ronald G. Crystal

×

Figure 2

Options: View larger image (or click on image) Download as PowerPoint
AdFcγRIIA induced binding and phagocytosis of opsonized SRBCs in vitro. ...
AdFcγRIIA induced binding and phagocytosis of opsonized SRBCs in vitro. A549 cells grown on coverslip dishes were infected with AdFcγRIIA, AdFcγRIIA mutant, and AdNull at 10 moi. After 48 hours, the cells were incubated with IgG-coated SRBCs for 60 minutes. To evaluate binding, cells were washed, fixed, and stained by Giemsa stain. To evaluate phagocytosis, cells were washed, SRBCs bound to the cell surface were lysed, and the A549 cells were fixed and stained by Giemsa stain or eosin as indicated. (a) Binding of opsonized SRBCs by naive cells. (b) Binding of opsonized SRBCs by AdNull-infected cells. (c) Binding of opsonized SRBCs by AdFcγRIIA mutant–infected cells. (d) Binding of opsonized SRBCs by AdFcγRIIA-infected cells. (e) Phagocytosis of opsonized SRBCs by naive noninfected cells. (f) Phagocytosis of opsonized SRBCs by AdNull-infected cells. (g) Phagocytosis of opsonized SRBCs by AdFcγRIIA mutant–infected cells. (h) Phagocytosis of opsonized SRBCs by AdFcγRIIA-infected cells. Large panels are original magnification ×400 (Giemsa stain). Shown in the insets are light microscopy of original magnification ×1,000 for a–d (Giemsa stain) and fluorescent microscopy of original magnification ×1,000 (eosin) for e–h.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts